# FDA Inspection 1220823 - Vitalant - October 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/05e33fa6-5685-44b8-a9b3-f594e7e231e1
Source feed: FDA_Inspections

> FDA Inspection 1220823 for Vitalant on October 12, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220823
- Company Name: Vitalant
- Inspection Date: 2023-10-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1106294 - 2019-08-27](https://www.keypedia.com/records/fda_inspections/vitalant/640c7f5c-d5ec-42b7-b55b-3ad9b39369ae)
- [FDA Inspection 923145 - 2015-04-21](https://www.keypedia.com/records/fda_inspections/vitalant/9a5af20a-72b0-4370-889a-c5b951ef003a)
- [FDA Inspection 816929 - 2013-02-01](https://www.keypedia.com/records/fda_inspections/vitalant/42dc1a37-d7cb-43b2-9122-4c81f0b9f71f)
- [FDA Inspection 731609 - 2011-06-24](https://www.keypedia.com/records/fda_inspections/vitalant/9395bfbc-8386-46b7-9f5a-60d6dfe2ec2b)
- [FDA Inspection 622905 - 2009-10-27](https://www.keypedia.com/records/fda_inspections/vitalant/5b449116-374b-4b43-9c38-401c94d0b360)

Company: https://www.keypedia.com/companies/vitalant/46d49348-5bb0-431a-afc9-d2af755accae

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d